(2Z,3E)-1-{[1,1'-biphenyl]-4-yl}-3-(methoxyimino)-2-[2-(4-methylphenyl)hydrazin-1-ylidene]propan-1-one

Catalog No. :
ACBCOJ399
CAS No. :
338965-35-8
Molecular Formula :
C23H21N3O2
Molecular Weight :
371.44

IUPAC Name:(1E,2Z)-3-([1,1'-biphenyl]-4-yl)-3-oxo-2-(2-(p-tolyl)hydrazineylidene)propanal O-methyl oxime

(2Z,3E)-1-{[1,1'-biphenyl]-4-yl}-3-(methoxyimino)-2-[2-(4-methylphenyl)hydrazin-1-ylidene]propan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2Z,3E)-1-{[1,1'-biphenyl]-4-yl}-3-(methoxyimino)-2-[2-(4-methylphenyl)hydrazin-1-ylidene]propan-1-one
IUPAC Name(1E,2Z)-3-([1,1'-biphenyl]-4-yl)-3-oxo-2-(2-(p-tolyl)hydrazineylidene)propanal O-methyl oxime
MDL No.MFCD00231438
Molecular FormulaC23H21N3O2
Molecular Weight371.44
SMILESO=C(C1=CC=C(C2=CC=CC=C2)C=C1)C(/C=N/OC)=N\NC3=CC=C(C)C=C3
InChI KeyAMMVMICDFMIZRT-KLCIZJNOSA-N
Synonym3-[1,1'-BIPHENYL]-4-YL-2-[2-(4-METHYLPHENYL)HYDRAZONO]-3-OXOPROPANAL O-METHYLOXIME;(2Z,3E)-1-{[1,1'-biphenyl]-4-yl}-3-(methoxyimino)-2-[2-(4-methylphenyl)hydrazin-1-ylidene]propan-1-one;[1,1'-Biphenyl]-4-propanal, α-[2-(4-methylphenyl)hydrazinylidene]-β-oxo-, 4-(O-methyloxime)
CAS No.338965-35-8

Synthetic Route by SureRoute

1. ACBCOJ399 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBCOJ399 route product structure diagram
    ACBCOJ399338965-35-8
Inquiry

2. ACBCOJ399 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBCOJ399 route product structure diagram
    ACBCOJ399338965-35-8
Inquiry

Comments (0)